+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Carbapenem"

Carbapenem-Based Antibiotics Market Report 2025 - Product Thumbnail Image

Carbapenem-Based Antibiotics Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Carbapenem - Global Strategic Business Report - Product Thumbnail Image

Carbapenem - Global Strategic Business Report

  • Report
  • May 2025
  • 383 Pages
  • Global
From
Carbapenem-Based Antibiotic Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Thumbnail Image

Carbapenem-Based Antibiotic Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • March 2025
  • 150 Pages
  • Global
From
Carbapenem Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2019-2029F - Product Thumbnail Image

Carbapenem Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2019-2029F

  • Report
  • May 2024
  • 185 Pages
  • Global
From
Carbapenem Drug Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Thumbnail Image

Carbapenem Drug Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • April 2025
  • 150 Pages
  • Global
From
Carbapenem-Resistant Enterobacteriaceae - Pipeline Insight, 2025 - Product Thumbnail Image

Carbapenem-Resistant Enterobacteriaceae - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 70 Pages
  • Global
From
Carbapenem-resistant Enterobacteriaceae Infection - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Carbapenem-resistant Enterobacteriaceae Infection - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • June 2024
  • 200 Pages
  • Global
From
Antibacterial Drugs Market by Drug Class (Aminoglycosides, Beta-Lactams, Glycopeptide), Route of Administration (Inhalation, Intramuscular, Intravenous), Spectrum of Activity, Mechanism of Action, Indication, Point of Sale, Distribution Channel - Global Forecast 2025-2030 - Product Thumbnail Image

Antibacterial Drugs Market by Drug Class (Aminoglycosides, Beta-Lactams, Glycopeptide), Route of Administration (Inhalation, Intramuscular, Intravenous), Spectrum of Activity, Mechanism of Action, Indication, Point of Sale, Distribution Channel - Global Forecast 2025-2030

  • Report
  • March 2025
  • 187 Pages
  • Global
From
Antibiotics Market by Action Mechanism, Drug Class, Spectrum, Category, Application, Route of Administration, Distribution Channel - Global Forecast 2025-2030 - Product Thumbnail Image

Antibiotics Market by Action Mechanism, Drug Class, Spectrum, Category, Application, Route of Administration, Distribution Channel - Global Forecast 2025-2030

  • Report
  • October 2024
  • 182 Pages
  • Global
From
Beta Lactam & Beta Lactamase Inhibitors Market by Drug Class, Disease, Route of Administration, Distribution Channels, End User, Drug Type - Global Forecast 2025-2030 - Product Thumbnail Image

Beta Lactam & Beta Lactamase Inhibitors Market by Drug Class, Disease, Route of Administration, Distribution Channels, End User, Drug Type - Global Forecast 2025-2030

  • Report
  • October 2024
  • 185 Pages
  • Global
From
Antibiotic Resistance Market Report 2025 - Product Thumbnail Image

Antibiotic Resistance Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Antibiotics - Global Strategic Business Report - Product Thumbnail Image

Antibiotics - Global Strategic Business Report

  • Report
  • May 2025
  • 266 Pages
  • Global
From
Beta Lactam and Beta Lactamase Inhibitors - Global Strategic Business Report - Product Thumbnail Image

Beta Lactam and Beta Lactamase Inhibitors - Global Strategic Business Report

  • Report
  • May 2025
  • 391 Pages
  • Global
From
Antibiotics Market Report by Action Mechanism, Drug Class, Spectrum of Activity, Route of Administration, End User, and Region 2024-2032 - Product Thumbnail Image

Antibiotics Market Report by Action Mechanism, Drug Class, Spectrum of Activity, Route of Administration, End User, and Region 2024-2032

  • Report
  • August 2024
  • 137 Pages
  • Global
From
Beta Lactam and Beta Lactamase Inhibitors Market 2025-2029 - Product Thumbnail Image

Beta Lactam and Beta Lactamase Inhibitors Market 2025-2029

  • Report
  • December 2024
  • 200 Pages
  • Global
From
Carbapenem-Resistant Enterobacteriaceae (CRE) Infection - Pipeline Insight, 2025 - Product Thumbnail Image

Carbapenem-Resistant Enterobacteriaceae (CRE) Infection - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Antibiotics - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Thumbnail Image

Antibiotics - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • July 2024
  • 100 Pages
  • Global
From
Antibiotics and Antimycotics Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Drug Class, Indication, Route of Administration, Distribution Channel, and Geography - Product Thumbnail Image

Antibiotics and Antimycotics Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Drug Class, Indication, Route of Administration, Distribution Channel, and Geography

  • Report
  • November 2024
  • 203 Pages
  • Global
From
Beta-Lactamase Inhibitor - Pipeline Insight, 2025 - Product Thumbnail Image

Beta-Lactamase Inhibitor - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Levofloxacin Hemihydrate Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2035F - Product Thumbnail Image

Levofloxacin Hemihydrate Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2035F

  • Report
  • January 2025
  • 183 Pages
  • Global
From
Loading Indicator

The Carbapenem market is a subset of the Antibiotics market, which is composed of drugs used to treat bacterial infections. Carbapenems are a class of antibiotics that are used to treat serious infections caused by bacteria that are resistant to other antibiotics. They are typically used as a last resort when other antibiotics have failed. Carbapenems are generally well-tolerated and have a low risk of side effects. Carbapenems are used to treat a wide range of infections, including pneumonia, urinary tract infections, and skin and soft tissue infections. They are also used to treat infections caused by multidrug-resistant bacteria, such as methicillin-resistant Staphylococcus aureus (MRSA). The Carbapenem market is highly competitive, with several major players. These include Merck & Co., Pfizer, GlaxoSmithKline, AstraZeneca, and Sanofi. Other companies in the market include Allergan, Novartis, and Daiichi Sankyo. Show Less Read more